Cell-surface F 1 F 0 -ATP synthase was involved in the cell signaling mediating various biological functions. Recently, we found that cell-surface F 1 F 0 -ATP synthase plays a role on intracellular triacylglycerol accumulation in adipocytes, and yet, the underlying mechanisms remained largely unknown. In this study, we investigated the role of extracellular ATP on the intracellular triacylglycerol accumulation. We demonstrated that significant amounts of ATP were produced extracellularly by cultured 3T3-L1 adipocytes and that the antibodies against α and β subunits of F 1 F 0 -ATP synthase inhibited the extracellular ATP production. Piceatannol, a F 1 F 0 -ATP synthase inhibitor, and apyrase, an enzyme which degrades extracellular ATP, suppressed triacylglycerol accumulation. The selective P2Y 1 receptor antagonist MRS2500 significantly inhibited triacylglycerol accumulation, whereas the selective P2X receptor antagonist NF279 has less effect. The present results indicate that cell-surface F 1 F 0 -ATP synthase on adipocytes is functional in extracellular ATP production and that the extracellular ATP produced contributes, at least in part, to the cell-surface F 1 F 0 -ATP synthase-mediated intracellular triacylglycerol accumulation in adipocytes through P2Y 1 receptor.
Mitochondrial F 1 F 0 -ATP synthase is responsible for the production of the majority of cellular ATP under aerobic conditions. Until recently, this enzyme was believed to be strictly confined to the inner mitochondrial membrane but recent studies proved the existence of this enzyme on the plasma membrane of tumor cells and some types of normal cells, such as hepatocytes, human umbilical vein endothelial cells (HUVEC), and adipocytes (8, 12, 17, 18) . Surprisingly, it has been shown that angiostatin, a potent inhibitor of angiogenesis, binds to the β-subunit of this enzyme on the surface of HUVEC and inhibits proliferation of HUVEC (18, 19) . Interestingly, cell-surface F 1 F 0 -ATP synthase catalyzes extracellular ATP synthesis from ADP and inorganic phosphate in HUVEC in which angiostatin inhibits the ATP synthesis activity (19) . We also showed that small molecules, such as resveratrol and piceatannol which have been shown to inhibit enzyme activity of F 1 F 0 -ATP synthase by targeting F 1 catalytic subunit of this enzyme, inhibited extracellular ATP synthesis and proliferation of HUVEC (1) . Furthermore, it has been shown that ectopic β-subunit of F 1 F 0 -ATP synthase is the receptor for apolipoprotein A-I, the major protein in hepatic high-density lipoprotein (HDL) and that binding of apolipoprotein A-I to the β-subunit triggers the endocytosis of holo-HDL particles (17) . Thus, membrane-bound F 1 F 0 -ATP synthase was suggested to have a previously unsuspected role in regulating cellular proliferation and hepatic HDL endocytosis.
according to the manufacturer's protocol.
Reverse transcription polymerase chain reaction (RT-PCR) analysis.
RNA preparation, synthesis of cDNA from the isolated total RNA, and RT were performed as described previously (14) . The primers used for PCR were as follows; for mouse GAPDH, 5'-AACTTTGGCATTGTGGAAGG-3' and 5'-ACA CATTGGGGGTAGGAACA-3'; for mouse P2Y 1 , 5'-CGACGAGGTTTATGCCACTT-3' and 5'-TCG TGTCTCCATTCTGCTTG-3'.
Determination of intracellular TG level. TG accumulation in adipocytes was evaluated by Oil-Red O staining and intracellular quantification as reported earlier (2, 14) . Briefly, 3T3-L1 adipocytes (day 16) were incubated with each sample for 48 h and then fixed by 10% formalin in phosphate-buffered saline, washed once with 60% isopropanol and then stained with Oil-Red O for 1 h at 37°C in a 5% CO 2 incubator. The stained cells were washed once rapidly with xylene, and then extracted with 600 μL of 99.5% ethanol. The extracts were stored at −20°C, and 10 μL of each extract was added to 90 μL of 99.5% ethanol; the absorbance was then read in the spectrophotometric plate reader at 490 nm.
Lipolysis assay. Differentiated 3T3-L1 adipocytes (day 16) were incubated with or without 0.1% dimethyl sulfoxide (DMSO) and the indicated concentrations of F 1 F 0 ATP synthase inhibitors for 48 h. The supernatant was then collected, and the glycerol released into the medium was measured as follows. Twentyfive microliters of samples or glycerol standard solution (1.3 mg/mL-260 μg/mL glycerol in culture medium) was added to a 96-well microtiter plate, and 200 μL of assay reagent (10 mM HEPES, pH 7.0, 0.25 mM ATP, 3.75 mM MgCl 2 , 0.188 mM 4-aminoantipyrine, 2.11 mM sodium-N-ethyl-N-(3-sulfopropyl) m-anisidine, 1.25 units/mL microbial glycerol kinase, 2.5 units/mL microbial glycerol phosphate oxidase, 1.25 units/mL horseradish peroxidase, 0.05% sodium azide) was then measured at 540 nm. Lipolysis data was normalized to total protein.
Statistical analysis. All analyses in this study were performed in three replicates. Differences were analyzed with the Student's t-test (2-tailed, paired) and probability values of P < 0.05 were considered significant. The results are presented as means ± standard deviations (SD).
Recently, we found that the cell-surface expression of the α subunit of F 1 F 0 -ATP synthase is markedly increased during adipocyte differentiation and that apolipoprotein A-I and antibodies against α and β subunits of this enzyme suppressed triacylglycerol (TG) accumulation in adipocytes (2) . We also found that F 1 F 0 -ATP synthase inhibitors, such as piceatannol and resveratrol, had cellular TG accumulation-lowering activity in adipocytes (2) . It is therefore suggested that the cell-surface F 1 F 0 -ATP synthase plays a role in TG accumulation in adipocytes. Nevertheless, the underlying mechanisms of cell-surface F 1 F 0 -ATP synthase-mediated intracellular TG accumulation remain unclear. Considering that extracellular ATP stimulates lipogenesis via P2-receptor in rat adipocytes (23) and that cell-surface F 1 F 0 -ATP synthase catalyzes extracellular ATP production (1, 12, 19) , we have investigated the role of extracellular ATP on the cellsurface F 1 F 0 -ATP synthase-mediated TG accumulation in adipocytes.
MATERIALS AND METHODS
Materials. Dulbecco's modified Eagle's medium (DMEM) was purchased from Wako (Osaka, Japan); fetal calf serum from Equitech-Bio Inc. (Cotton Gin Lane, Kerrville, TX); mouse monoclonal antibodies against bovine mitochondrial F 1 F 0 -ATP synthase α (Vα) and β (Vβ) subunits from Molecular Probes (Eugene, OR); NF279 from Cosmo Bio Co. LTD. (Tokyo, Japan); MRS2500 from Tocris Bioscience (Bristol, UK); apyrase from SIGMA (St. Louis, MO).
Cell culture and differentiation. Murine 3T3-L1 preadipocytes were maintained in DMEM with 10% (v/ v) fetal calf serum and each sample in a humidified atmosphere of 95% air and 5% CO 2 at 37°C. Adipocyte differentiation was performed as described previously (2).
Determination of ATP. Extracellular ATP was determined using the cellular ATP assay reagent (Toyo-B-net, Tokyo). Briefly, 3T3-L1 adipocytes (day 16) cultured on the 96-well plates were incubated with each sample for 48 h, and cell-culture supernatants were collected. An aliquot of 100 μL of each supernatant was added to the 96-well plate, and then 100 μL of ATP assay reagent was added. After 1 min of shaking and 10 min of incubation at 23°C, luminescence was detected with a microplate reader. Intracellular ATP was determined using the same cells (after their supernatants were collected) and reagents cellular ATP contributes to the cell-surface F 1 F 0 -ATP synthase-mediated TG accumulation.
Effects of antagonists for prinoreceptors on intracellular TG accumulation and lipolysis
Extracellular ATP was thought to act through purinoreceptors P2X or P2Y and adipocytes were reported to express mainly P2X 1 , P2Y 1 , P2Y 2 and P2Y 4 receptors (3-5, 11, 24 ). Then we next examined the effects of specific antagonists for P2X or P2Y receptors on the intracellular TG accumulation. In this study, we used NF279 as a selective antagonist for P2X; it has IC50 values of 19 nM, 770 nM, 1.62 μM, and 300 μM against P2X 1 , P2X 2 , P2X 3 , and P2X 4 , respectively (15, 22) and MRS2500 was used as a selective antagonist for P2Y 1 receptor that has an IC50 value of 0.95 nM against P2Y 1 (7, 9) . As shown in Fig. 3A , MRS2500 at 1 nM markedly inhibited intracellular TG contents, while NF279 at 1 μM and 10 μM had no effect on intracellular TG contents. Furthermore, we found that the expression of P2Y 1 receptor was markedly increased in differentiated adipocytes accompanied by enhanced TG accumulation (2), although it was barely detectable in pre-adipocytes (Fig. 3B) . The result also supports that P2Y 1 receptor is responsible for ATP signaling related to the intracellular TG accumulation in differ-
RESULTS

Cell-surface F 1 F 0 -ATP synthase is required for the production of extracellular ATP
To evaluate the role of extracellular ATP on the cellsurface F 1 F 0 -ATP synthase-mediated TG accumulation, we first determined the extracellular ATP production in cultured adipocytes and then the effects of antibodies against α and β subunits of F 1 F 0 -ATP synthase on the ATP production were determined. As shown in Fig. 1 , significant amounts of extracellular ATP was produced by cultured adipocytes (Fig. 1A) and the antibodies against this enzyme (Vα and Vβ) markedly inhibited extracellular ATP production, while intracellular ATP content was not affected by the antibodies (Fig. 1B) .
Extracellular ATP is responsible for the cell-surface F 1 F 0 -ATP synthase-mediated TG accumulation
We next examined the effects of apyrase which degrades extracellular ATP and piceatannol, an F 1 F 0 -ATP synthase inhibitor, on TG accumulation. As shown in Fig. 2 , intracellular TG level was markedly increased after the induction of adipocyte differentiation, but the treatment of the cells with apyrase (AP) and piceatannol (P) caused a reduction of TG accumulation. However, no additive effects of apyrase and piceatannol were found, suggesting that extra- Fig. 1 Inhibition of extracellular ATP production by antibodies against α and β subunits of F 1 F 0 -ATP synthase. Induction of differentiation of 3T3-L1 preadipocytes was performed as previously described in MATERIALS AND METHODS. After 16 days from induction of differentiation (day 16), cells were treated with 40 μg/mL of mouse IgG (mIgG) or monoclonal antibodies against α (Vα) or β (Vβ) subunits of F 1 F 0 -ATP synthase for 48 h, and then intracellular and extracellular ATP was determined using ATP assay reagent. Results are shown as means ± SD of 3 separate experiments. pre: preadiocytes. by inhibition of lipolysis. DISCUSSION F 1 F 0 -ATP synthase is composed of a membrane F 0 region and a catalytic F 1 region. The F 1 complex, which consists of the five subunits (α 3 , β 3 , γ, δ, and ε), catalyzes the synthesis of ATP from ADP and inorganic phosphate (6) . On the cell surface, F 1 is oriented extracellularly, localizing ATP synthesis to the external cell surface (2, 12, 17, 18) . The findings that cultured adipocytes can synthesize ATP extracellularly and that the antibodies (Vα and Vβ) against this enzyme almost completely inhibited extracellular ATP production indicate that cell-surface F 1 F 0 -ATP synthase catalyzes extracellular ATP synthesis. Furthermore, the findings that treatment of differentiated adipocytes with apyrase which degrades extracellular ATP and piceatannol, an F 1 F 0 -ATP synthase inhibitor, caused a decrease in TG accumulation and that no additive effect of apyrase and piceatannol on TG accumulation was found, suggest that extracellular ATP contributes to the cell-surface F 1 F 0 -ATP synthase-mediated TG accumulation. In this study, we used piceatannol as an F 1 F 0 -ATP synthase inhibitor based on the findings that piceatannol inhibits mitochondrial F 1 F 0 -ATP synthase by targeting the F 1 complex (27) and that piceatannol mimics the effects of antibodies against F 1 F 0 -ATP synthase on TG accumulation, mitochondrial fusion activity and inhibition of cell proliferation (1, 2, 14, 19 ). In addition, high-resolution crystallographic studies for the inhibition site of piceatannol in the F 1 complex showed that piceatannol binds to the F 1 F 0 -ATP synthase inhibitor aurovertin B-binding site in the F 1 region (9). Although whether F 1 F 0 -ATP synthase on the cell surface is piceatannol's only target remains to be determined, these results show that cell-surface F 1 F 0 -ATP synthase is the most important target molecule for piceatannol. Current results also suggest that extracellular ATP acts, at least in part, through the P2Y 1 receptor. The marked increase of P2Y 1 expression increased in differentiated adipocytes also supports that P2Y 1 receptor is responsible for the extracellular ATP-mediated intracellular TG accumulation in differentiated adipocytes. The signal transduction mechanism responsible for the extracellular ATP-mediated TG accumulation is not clear at present, however, it is conceivable that extracellular ATP produced by cell-surface F 1 F 0 -ATP synthase changes the responsiveness of preadipocytes to hormonal adipogenic stimuli, resulting in the increase of intracellular TG accumulation as reported by entiated adipocytes. Interestingly, MRS2500 (M) and F 1 F 0 ATP synthase inhibitors including piceatannol (P) and resveratrol (R) which have TG accumulation-lowering activity stimulated lipolysis by ~175% to ~240% of control (Fig. 3C) . Therefore, it is likely that extracellular ATP stimulates intracellular TG accumulation possibly by activation of lipogenesis and Fig. 3 Effects of specific antagonists for P2X or P2Y receptors on the intracellular TG accumulation and lipolysis. (A) 3T3-L1 adipocytes (day 16) were treated with or without NF279 (a selective antagonist for P2X receptors) or MRS2500 (a selective antagonist for P2Y 1 receptor) and then TG level was determined. The asterisk indicates statistical significance compared to the value without MRS2500 (*P < 0.05). (B) P2Y 1 receptor expression at day 0 and day 16. RT-PCR analysis for P2Y 1 was performed as described in Materials and Methods. The data shown are representative of two independent experiments that gave similar results. GAPDH was used as the internal control to normalize gene expression. (C) Effects of MRS2500 and F 1 F 0 ATP synthase inhibitors on lipolysis. 3T3-L1 adipocytes (day 16) were treated with or without DMSO (D), MRS2500 (M) (1 nM), resveratrol (R) (50 μM) or piceatannol (P) (50 μM) and then lipolysis activity was determined as described in Materials and Methods. Results are shown as means ± SD of 3 separate experiments. The asterisk indicates statistical significance compared to the value in DMSO control group. (*P < 0.05).
Omatsu-Kanbe et al. (20) . On the other hand, P2Y 1 receptor is a heterotrimeric G-protein-coupled receptor and activates G(q) and therefore robustly promotes inositol lipid signaling responses (21) . Considering that the activation of phosphoinositide-3-kinase (PI3K)-Akt pathway stimulates adipogenic differentiation (13, 26) , it is possible that the PI3K-Akt pathway is involved in extracellular ATP-stimulated TG accumulation via P2Y 1 receptor. Furthermore, cellsurface F 1 F 0 -ATP synthase is concentrated in lipid rafts (12, 25) . Therefore, the increase of F 1 F 0 -ATP synthase complex in lipids rafts during adipocyte differentiation (12) would change in lipid microenvironments on the cell surface, resulting in the activation of many signal transduction pathways involved in intracellular TG accumulation. Further studies are needed to fully understand the role of cell-surface F 1 F 0 -ATP synthase in the cell signaling mediating various biological functions. Finally, cell-surface F 1 F 0 -ATP synthase involved in the regulation of various biological functions including cell proliferation, hepatic HDL endocytosis, and lipid metabolism. Elucidation of signal transduction mechanism of cell-surface F 1 F 0 -ATP synthase-mediated biological effects might lead to the development of a potential and novel therapeutic target for treatment of tumor angiogenesis, atherosclerosis and lipid disorders.
